Results 101 to 110 of about 27,689 (240)

Sporadic Burkitt Lymphoma Presenting as Acute Pancreatitis, Concurrent Sinusitis, and Enlarged Adenoids

open access: yesCase Reports in Pediatrics, 2016
Pancreatitis and sinusitis as presentations of Burkitt lymphoma are uncommon and rarely described in children. We describe here the case of a child who presented with symptoms suggestive of sinusitis unresponsive to antibiotics, with subsequent ...
Vasudha Mahajan   +5 more
doaj   +1 more source

Burkitt lymphoma [PDF]

open access: yesBritish Journal of Haematology, 2017
Daniela Fonseca e Silva   +5 more
openaire   +2 more sources

Integrative Multi‐Omics Analysis Reveals the Tumor‐Suppressive and Immunoregulatory Roles of SEMA5B in Prostate Cancer

open access: yesBioFactors, Volume 52, Issue 4, July/August 2026.
This study identifies SEMA5B as a tumor suppressor in prostate cancer that suppresses the malignant phenotype, affects mitochondrial oxidative metabolism, induces cell cycle arrest and apoptosis, and is associated with the immune‐inflammatory tumor microenvironment, highlighting its potential as a biomarker and target for immunotherapy. ABSTRACT SEMA5B
Zhiguo Fan   +8 more
wiley   +1 more source

Cytokeratin Detection in Lymphoid Tumor Cell Lines: Implications for Flow Cytometry and Molecular Analyses

open access: yesCell Biology International, Volume 50, Issue 7, July 2026.
ABSTRACT Cytokeratins are widely used as epithelial markers in diagnostic pathology and flow cytometry, and malignant lymphomas are generally considered cytokeratin‐negative except for undifferentiated large cell lymphomas. During antibody screening experiments using flow cytometry, intracellular cytokeratin signals were unexpectedly detected in ...
Natsuko Mizutani   +13 more
wiley   +1 more source

Burkitt-like lymphoma with 11q aberration: A germinal center derived lymphoma genetically unrelated to Burkitt lymphoma [PDF]

open access: yes
Burkitt-like lymphoma with 11q aberration is characterized by pathological features and gene expression profile resembling Burkitt lymphoma but lack MYC rearrangement and carries an 11q-arm aberration with proximal gains and telomeric losses.
Celis, Verónica   +18 more
core  

Relapsed/refractory Burkitt lymphoma and HIV infection [PDF]

open access: yes, 2017
The care of patients with HIV and Burkitt lymphoma poses a challenge to clinicians. Due to the limited treatment options that exist for relapsed/refractory Burkitt lymphoma, there is a need for the development of new therapies.
Amanda Brahim   +3 more
core   +1 more source

Mothers' Role Towards Management of Their Children with Burkitt's Lymphoma [PDF]

open access: yesEgyptian Journal of Health Care
Background: Mothers of children with Burkitt lymphoma play a crucial role in the process of children’s management and full fling the children’s needs during the treatment period.
Hend Alaa Ahmed   +2 more
doaj   +1 more source

Dietary Polyphenols as Natural Modulators of NF‐κB Signaling in Inflammation‐Driven Non‐Communicable Diseases: Focus on Cancer

open access: yesFood Science &Nutrition, Volume 14, Issue 7, July 2026.
Dietary polyphenols and phytochemicals suppress NF‐κB signaling. Mechanistically, by inhibiting IκBα degradation and preventing nuclear translocation of p65/p50 complexes, the polyphenols reduce the expression of pro‐inflammatory and pro‐survival genes, thereby decreasing overall cancer cell survival.
Khuzin Dinislam   +3 more
wiley   +1 more source

Neoplasias de células linfoides maduras B: avaliação dos casos diagnosticados e acompanhados no hospital universitário da Universidade Federal de Santa Catarina entre 2011 e 2014 [PDF]

open access: yes, 2015
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Programa de Pós-Graduação em Farmácia, Florianópolis, 2015.De acordo com a classificação da OMS (2008), as neoplasias de células maduras B (NCLM-B) abrangem os ...
Cardoso, Chandra Chiappin
core  

Preclinical evaluation of the ROR1‐targeting antibody–drug conjugates zilovertamab vedotin and VLS‐211 against B‐cell ALL patient‐derived xenografts

open access: yesHemaSphere, Volume 10, Issue 7, July 2026.
Abstract Although survival rates for acute lymphoblastic leukemia (ALL) have improved dramatically over the past 60 years, outcomes vary across different molecular subtypes and risk categories, and a significant number of patients remain difficult to treat.
Christopher M. Smith   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy